Prioritizing the development of mouse models for childhood brain disorders
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Mutations in hundreds of genes contribute to cognitive and behavioral dysfunction associated with developmental brain disorders (DBDs). Due to the sheer number of risk factors available for study combined with the cost of developing new animal models, it remains an open question how genes should be prioritized for in-depth neurobiological investigations. Recent reviews have argued that priority should be given to frequently mutated genes commonly found in sporadic DBD patients. Intrigued by this idea, we explored to what extent “high priority” risk factors have been studied in animals in an effort to assess their potential for generating valuable preclinical models capable of advancing the neurobiological understanding of DBDs. We found that in-depth whole animal studies are lacking for many high priority genes, with relatively few neurobiological studies performed in construct valid animal models aimed at understanding the pathological substrates associated with disease phenotypes. However, some high priority risk factors have been extensively studied in animal models and they have generated novel insights into DBD patho-neurobiology while also advancing early pre-clinical therapeutic treatment strategies. We suggest that prioritizing model development toward genes frequently mutated in non-specific DBD populations will accelerate the understanding of DBD patho-neurobiology and drive novel therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“Several groups have found damaging SYNGAP1 mutations or copy number variations in ASD patients (De Rubeis et al., 2014; Iossifov et al., 2014; O'Roak et al., 2014; Pinto et al., 2010).”
BackgroundDefault-mode brain dysfunction in mental disorders: A systematic review
Broyd, S. J., Demanuele, C., Debener, S., Helps, S. K., James, C. J., & Sonuga-Barke, E. J. S. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.09.002 · Cited by 1,675 · cited 1×
“Furthermore, abnormal local- and long-distance connectivity is believed to underlie functional deficits in DBDs (Broyd et al., 2009; Just et al., 2004).”
BackgroundDe novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617
Just, M. A. (2004) · Brain · doi:10.1093/brain/awh199 · Cited by 1,589 · cited 1×
“Furthermore, abnormal local- and long-distance connectivity is believed to underlie functional deficits in DBDs (Broyd et al., 2009; Just et al., 2004).”
BackgroundThe mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 1×
“Preclinical studies in construct valid animal models of these strong syndromic disorders have dramatically advanced our understanding of the neurobiological defects caused by gene disruptions associated with syndromic DBDs (Bear et al., 2004; Ehninger et al., 2008; Zoghbi and Bear, 2012).”
BackgroundDiagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546 · cited 6×
“An increasing number of non-specific DBD patients are being genetically screened in an attempt to improve diagnostic yield (de Ligt et al., 2012; Deciphering Developmental Disorders, 2015; Epi et al., 2013; Redin et al., 2014).”
BackgroundResultInfluentialDendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
De novo mutations in epileptic encephalopathies
Epi4K Consortium, & Epilepsy Phenome/Genome Project (2013) · Nature · doi:10.1038/nature12439 · Cited by 1,514
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385 · cited 2×
“…ID and SCZ, and severe childhood epilepsies (de Ligt et al., 2012; Epi et al., 2013; Fromer et al., 2014; Iossifov et al., 2014; Kenny et al., 2014; Krumm et al., 2014; O'Roak et al., 2011; O'Roak et al., 2014; O'Roak et al., 2012; Purcell et al., 2014; Rauch et al., 2012; Samocha et al., 2014).”
BackgroundDe Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292 · cited 1×
“Shortly after the discovery of SCN1A mutations in GEFS+, SCN1A mutations were identified in patients with Dravet Syndrome, or severe myoclonic epilepsy of infancy (Claes et al., 2001).”
Background
Cited by
Prata, J., Santos, S. G., Almeida, M. I., Coelho, R., & Barbosa, M. A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0938-y · Cited by 115
Canonical and non-canonical Reelin signaling
Bock, H. H., & May, P. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00166 · Cited by 107
Connor, S. A., Ammendrup-Johnsen, I., Chan, A. W., Kishimoto, Y., Murayama, C., Kurihara, N., Tada, A., Ge, Y., Lu, H., Yan, R., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.016 · Cited by 100
Current perspectives in autism spectrum disorder: from genes to therapy
Chahrour, M., O'Roak, B. J., Santini, E., Samaco, R. C., Kleiman, R. J., & Manzini, M. C. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2335-16.2016 · Cited by 54
“As described above, multiple animal models have been developed to study ASD using paradigms aimed at capturing behavioral deficits that resemble features of the human disease (for review, see Ey et al., 2011; Ogden et al., 2016).”
Background
Metadata
- Authors
- Ogden, K. K., Ozkan, E. D., & Rumbaugh, G.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 100
- Pages
- 2-16
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W1408742906
- Cited by
- 18
- References
- 55
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prioritizing the development of mouse models for childhood brain disorders. https://app.cochat.ai/papers/10.1016/j.neuropharm.2015.07.029
- The paper
- Ogden, K. K., Ozkan, E. D., & Rumbaugh, G. (2016). Prioritizing the development of mouse models for childhood brain disorders. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2015.07.029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.